← Back to Search

Cognitive Processing Therapy for PTSD (CF-CPT Trial)

N/A
Waitlist Available
Led By Tara Ellen Galovski, PhD MA BS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Serious drug or alcohol abuse that requires immediate medical attention (e.g. inpatient care)
Current mania
Timeline
Screening 3 weeks
Treatment Varies
Follow Up administered at baseline, mid-treatment (after session 6), two weeks following treatment (post-treatment), and at the 3-month follow-up interval.
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the efficacy of cognitive processing therapy (CPT) to cognitive processing therapy with case formulation (CF-CPT) in treating PTSD among US Veterans.

Who is the study for?
This trial is for US Veterans with PTSD who are not currently experiencing severe mental health issues like active suicidal thoughts, homicidal tendencies, mania, psychosis, or serious substance abuse needing immediate attention. They shouldn't be in another trauma-focused therapy but can continue stable psychiatric medications.
What is being tested?
The study compares two methods of treating PTSD: standard Cognitive Processing Therapy (CPT) and a personalized version that includes Case Formulation (CF-CPT). It aims to see if CF-CPT improves psychosocial functioning and quality of life more than CPT alone over treatment and follow-up periods.
What are the potential side effects?
While specific side effects are not listed for these therapies, psychological interventions may sometimes cause temporary increases in distress due to discussing traumatic events or changes in mood and behavior as individuals work through their experiences.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not need immediate medical help for drug or alcohol use.
Select...
I am currently experiencing a manic episode.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~administered at baseline, mid-treatment (after session 6), two weeks following treatment (post-treatment), and at the 3-month follow-up interval.
This trial's timeline: 3 weeks for screening, Varies for treatment, and administered at baseline, mid-treatment (after session 6), two weeks following treatment (post-treatment), and at the 3-month follow-up interval. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Clinician-Administered PTSD Scale-5 (CAPS) (assessing change over time)
Inventory of Psychosocial Functioning (assessing change over time)
Secondary study objectives
Beck Suicidal Ideation Scale (assessing change over time)
Brief Addiction Monitor (assessing change over time)
DSM-5 Cross-cutting symptom measure (CCSM) (assessing change over time)
+18 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Case Formulation plus Cognitive Processing TherapyExperimental Treatment1 Intervention
The CF approach alters the CPT protocol in two ways: expanding the protocol to intentionally and systematically address impairment in functioning, and enhancing the providers' latitude to navigate challenges to optimal therapy outcomes (COTOS). CF-CPT begins with a formal CF assessment session; elements of CF are then integrated throughout CPT. CF modifications to the original CPT protocol occur in each session by intentionally attending to cognitions that are impeding the patient's functional recovery. The second modification includes enhancing the provider's latitude to diverge from the protocol when clinically wise. CF-CPT provides guidance around the identification, monitoring and management of COTOs, and, importantly, the expedient return to the CPT protocol with continued attention to COTOs.
Group II: Cognitive Processing TherapyActive Control1 Intervention
CPT is a brief therapy for PTSD predominantly based on cognitive theory. Traditionally delivered over 12 one-hour sessions weekly or twice weekly, CPT is now variable length depending on patient's recovery from PTSD. CPT is delivered in three phases: education, processing, and challenging and focuses on challenging beliefs and assumptions related to the trauma, oneself, and the world. Changing dysfunctional beliefs alters negative emotions emanating from those beliefs.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,633 Total Patients Enrolled
Tara Ellen Galovski, PhD MA BSPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Shannon M. Kehle-Forbes, PhDPrincipal InvestigatorMinneapolis VA Health Care System, Minneapolis, MN
2 Previous Clinical Trials
102 Total Patients Enrolled

Media Library

Case Formulation plus Cognitive Processing Therapy Clinical Trial Eligibility Overview. Trial Name: NCT04407767 — N/A
Post-Traumatic Stress Disorder Research Study Groups: Case Formulation plus Cognitive Processing Therapy, Cognitive Processing Therapy
Post-Traumatic Stress Disorder Clinical Trial 2023: Case Formulation plus Cognitive Processing Therapy Highlights & Side Effects. Trial Name: NCT04407767 — N/A
Case Formulation plus Cognitive Processing Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04407767 — N/A
~15 spots leftby Mar 2025